Medical outcomes in African American live kidney donors: A matched cohort study

American Journal of Transplantation

Volumn 13, Issue 1, 2013, Pages 111-118

  Doshi, M D ^a   Goggins, M O ^b   Li, L ^c   Garg, A X ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

African American; hypertension; kidney function; live kidney donors; race

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DONOR; LIVE KIDNEY DONOR; MALE; MICROALBUMINURIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TRANSPLANTATION; MALE; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84871715921     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04303.x     Document Type: Article

References (36)

1. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S,. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995; 333: 333-336.
2. Axelrod DA, McCullough KP, Brewer ED, Becker BN, Segev DL, Rao PS,. Kidney and pancreas transplantation in the United States, 1999-2008: The changing face of living donation. Am J Transplant 2010; 10 (4 Pt 2): 987-1002.
3. Horvat LD, Shariff SZ, Garg AX,. Global trends in the rates of living kidney donation. Kidney Int 2009; 75: 1088-1098.
4. Najarian JS, Chavers BM, McHugh LE, Matas AJ,. 20 years or more of follow-up of living kidney donors. Lancet 1992; 340: 807-810.
5. Segev DL, Muzaale AD, Caffo BS, et al.. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010; 303: 959-966.
6. Garg AX, Meirambayeva A, Huang A, et al.. Cardiovascular disease in kidney donors: Matched cohort study. BMJ 2012; 344: e1203.
7. Ibrahim HN, Foley R, Tan L, et al.. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459-469.
8. Lentine KL, Schnitzler MA, Xiao H, et al.. Racial variation in medical outcomes among living kidney donors. N Engl J Med 2010; 363: 724-732.
9. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ,. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52: 818-827.
10. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ,. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA 1992; 268: 3079-3084.
11. Carter JS, Pugh JA, Monterrosa A,. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996; 125: 221-232.
12. Nogueira JM, Weir MR, Jacobs S, et al.. A study of renal outcomes in African American living kidney donors. Transplantation 2009; 88: 1371-1376.
13. Parasuraman R, Venkat KK,. Utility of estimated glomerular filtration rate in live kidney donation. Clin J Am Soc Nephrol 2008; 3: 1608-1609.
14. Laskow DA, Jones P, Deierhoi MH, et al.. Are black living-related renal donors at greater long-term risk of renal complications than white donors? Transplant Proc 1991; 23 (1 Pt 2): 1328-1329.
15. Reeves-Daniel A, Freedman BI, Assimos D, et al.. Short-term renal outcomes in African American and Caucasian donors following live kidney donation. Clin Transplant 2010; 24: 717-722.
16. Doshi M, Garg AX, Gibney E, Parikh C,. Race and renal function early after live kidney donation: An analysis of the United States Organ Procurement and Transplantation Network Database. Clin Transplant 2010; 24: E153-E157.
17. Budisavljevic MN, Nietert PJ, Zhai Y, Dooley MJ, Rajagopalan PR,. Long-term effects of kidney donation on renal function and blood pressure in African Americans. Clin J Am Soc Nephrol 2011; 6: 1474-1480.
18. Lin J, Kramer H, Chandraker AK,. Mortality among living kidney donors and comparison populations. N Engl J Med 2010; 363: 797-798.
19. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP,. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349.
20. Murata K, Baumann NA, Saenger AK, Larson TS, Rule AD, Lieske JC,. Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol 2011; 6: 1963-1972.
21. Levey AS, Stevens LA, Schmid CH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
22. Seventh Report of the Joint National Committee on Prevention D, Evaluation, and Treatment of High Blood Pressure 2010/09/08 ed2004.
23. Wilson DM, Bergert JH, Larson TS, Liedtke RR,. GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis 1997; 30: 646-652.
24. Friedman GD, Cutter GR, Donahue RP, et al.. CARDIA: Study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988; 41: 1105-1116.
25. CARDIA Exam Components-All Years. 2010; Available at: http://www.cardia.dopm.uab.edu/exam-materials2/exam-components. Accessed October 3, 2012.
26. Delmonico FA,. Report of the Amsterdam Forum on the care of the live kidney donor: Data and medical guidelines. Transplantation 2005; 79 (Suppl 6): S53-S66.
27. Sorensen HT, Gillman MW,. Matching in case-control studies. BMJ 1995; 310: 329-330.
28. Mattix HJ, Hsu CY, Shaykevich S, Curhan G,. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002; 13: 1034-1039.
29. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35 Suppl 1: S11-S63.
30. Koepsell TWN,. Epidemiologic Methods: Studying the Occurrence of Illness. Oxford: Oxford University Press; 2003.
31. Zou G,. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-706.
32. Gibney EM, Doshi MD, Hartmann EL, Parikh CR, Garg AX,. Health insurance status of US living kidney donors. Clin J Am Soc Nephrol 2010; 5: 912-916.
33. Lewis J, Agodoa L, Cheek D, et al.. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 2001; 38: 744-753.
34. Garg AX, Muirhead N, Knoll G, et al.. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int 2006; 70: 1801-1810.
35. Genovese G, Friedman DJ, Ross MD, et al.. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
36. Sickand M, Cuerden MS, Klarenbach SW, et al.. Reimbursing live organ donors for incurred non-medical expenses: A global perspective on policies and programs. Am J Transplant 2009; 9: 2825-2836.